IDEAYA Biosciences (NASDAQ: IDYA) reported Q4 EPS of ($0.94), in-line with the analyst estimate of ($0.94). Revenue for the quarter came in at $10.88 million versus the consensus estimate of $6.12 million.

For earnings history and earnings-related data on IDEAYA Biosciences (IDYA) click here.